We are live on ! Find out more
TSV

Two Sigma Ventures Portfolio holdings

AUM $9.61M
1-Year Est. Return 58.41%
This Fund
S&P 500
This Quarter Est. Return
-57.85%
1 Year Est. Return
-58.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.3M
AUM Growth
-$33.1M
Cap. Flow
-$9.34M
Cap. Flow %
-53.95%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$9.34M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.84B
$12.9M 74.73%
1,806,800
ZY
2
DELISTED
Zymergen Inc. Common Stock
ZY
$4.38M 25.27%
1,513,727
GTLB icon
3
GitLab
GTLB
$7.57B
-107,357
Closed -$9.34M

Similar funds

Two Sigma Ventures's Q1 2022 Portfolio in Review

As of Q1 2022, Two Sigma Ventures held 3 positions worth $17.3M, down 66% from $50.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Two Sigma Ventures withdrew a net $9.34M in Q1 2022, closing 1 position. Its most notable exit was GitLab, an estimated $9.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 81% a quarter earlier, followed by Technology.

  • Two Sigma Ventures fully exited GitLab in Q1 2022, selling an estimated $9.34M.
  • Two Sigma Ventures's ten largest holdings make up 100% of its $17.3M portfolio in Q1 2022.
  • Two Sigma Ventures opened 0 new positions and closed 1 in Q1 2022.
  • Two Sigma Ventures's portfolio value fell 66% quarter-over-quarter to $17.3M.

Based on Two Sigma Ventures's 13F filing for Q1 2022, filed 16 May 2022.